![[ Visit SHEA online ]](images/banner.gif)
Friday, April 1, 2011: 5:00 PM-7:00 PM
Chantilly Ballroom (Hilton Anatole)
CME Credits: 2
Type: Plenary Sessions
Summary: Public policy approaches to preventing HAIs have evolved rapidly in the past five years, moving beyond mandates for public reporting and pathogen-specific surveillance. Government, business, and healthcare stakeholders are driving policy innovations in payment/reimbursement, quality improvement and measurement, and behavior change and implementation. This session outlines key policy initiatives of a primary policy actor – CMS – and efforts to evaluate the impact of those policies and measure progress toward preventing HAIs. Attendees will also learn about the important policy perspectives and contributions from the field of healthcare epidemiology, that are represented by SHEA.
Learning Objectives: - Identify key initiatives CMS is undertaking to prevent HAIs, including value-based purchasing and effective measurement and reporting
- Discuss policy mechanisms that CMS is using to drive change in healthcare institutions
- Discuss the linkage between federal and state/local public health policy to eliminate HAIs
- Assess Data to drive change and evaluate improvement in the prevention of HAIs
- Apply wider public health examples to evaluate effective policy mechanisms to eliminate HAIs
- Evaluate current data on the impact of policy changes (e.g. reimbursement) in healthcare settings
- Identify priority research initiatives that can most influence future policy discussions
Endorsed by:
- American Hospital Association
- Center for Disease Control and Prevention
- Extending the Cure Project of the Center for Disease Dynamics, Economics & Policy
- Infusion Nurses Society
- Pediatric Infectious Diseases Society
Moderators:
Steven M. Gordon, MD
,
Russell N. Olmstead, MPH, CIC
and
Tammy Lundstrom, MD, JD
5:00 PM
18A
5:30 PM
18B